Understanding the role of individualized nutrition and exercise intervention program on body composition in breast cancer patients undergoing anti-neoplastic treatment
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2023 - 2025
Project Lead
Dr Sucharita S
Authors
Dr Sucharita S, Dr Jyothi P, Dr Ganapathi B
Project Status
ongoing
Project Type
Government (Funded by ICMR)